Trinbelimab (r-anti-D) is a recombinant anti-Rh (o) -D immunoglobulin. Trinbelimab can be used for the prevention of immune reactions caused by Rh (D) blood group incompatibility between mother and fetus, as well as for research on hemolytic disease of the fetus/newborn (HDFN) [1].